Stocktoria
Coloplast A/S COLO-B.CO
Coloplast A/S statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (kr 209.10); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Coloplast A/S trades at about 19.1× earnings — below its 10-year norm (10-year range 33.1×–46.4×, median 38.1×).
Shaded band = 10-year range (33.1×–46.4×); dot = today's 19.1×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Gross margin | 67.6% | 66.6% | 68.8% | 68.5% |
| Operating margin | 27.0% | 27.9% | 30.6% | 32.7% |
| Net margin | 18.7% | 19.5% | 20.8% | 24.8% |
| FCF margin | 5.3% | 12.2% | 17.6% | 17.1% |
| Return on assets | 10.5% | 9.9% | 12.6% | 30.5% |
| Return on equity | 28.2% | 27.6% | 56.8% | 59.1% |
| Debt / equity | 0.92× | 0.67× | 1.97× | 0.00× |
| Current ratio | 1.02 | 0.61 | 1.20 | 1.11 |
Computed from company filings · DK · as of 2024-09-30. Figures in DKK. Facts plus Stocktoria's own computed scores — not investment advice.